Barclays’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-109,656
Closed -$4.21M 4480
2023
Q2
$4.21M Buy
109,656
+25,731
+31% +$989K ﹤0.01% 1315
2023
Q1
$1.94M Sell
83,925
-18,016
-18% -$417K ﹤0.01% 1673
2022
Q4
$2.67M Buy
101,941
+9,670
+10% +$253K ﹤0.01% 1461
2022
Q3
$1.81M Buy
92,271
+87,934
+2,028% +$1.73M ﹤0.01% 1727
2022
Q2
$75K Sell
4,337
-4,053
-48% -$70.1K ﹤0.01% 3586
2022
Q1
$137K Buy
+8,390
New +$137K ﹤0.01% 3529
2020
Q4
Sell
-7,931
Closed -$97K 3755
2020
Q3
$97K Sell
7,931
-1,212
-13% -$14.8K ﹤0.01% 3049
2020
Q2
$105K Buy
9,143
+4,772
+109% +$54.8K ﹤0.01% 3101
2020
Q1
$60K Sell
4,371
-8,829
-67% -$121K ﹤0.01% 3023
2019
Q4
$78K Buy
13,200
+6,438
+95% +$38K ﹤0.01% 3501
2019
Q3
$36K Sell
6,762
-4,791
-41% -$25.5K ﹤0.01% 3761
2019
Q2
$89K Buy
11,553
+3,973
+52% +$30.6K ﹤0.01% 3644
2019
Q1
$151K Buy
7,580
+7,084
+1,428% +$141K ﹤0.01% 3155
2018
Q4
$7K Sell
496
-8,590
-95% -$121K ﹤0.01% 3658
2018
Q3
$334K Buy
9,086
+3,854
+74% +$142K ﹤0.01% 2828
2018
Q2
$182K Sell
5,232
-8,545
-62% -$297K ﹤0.01% 2794
2018
Q1
$641K Buy
13,777
+7,657
+125% +$356K ﹤0.01% 2113
2017
Q4
$231K Sell
6,120
-5,764
-49% -$218K ﹤0.01% 2572
2017
Q3
$634K Buy
11,884
+7,560
+175% +$403K ﹤0.01% 1795
2017
Q2
$246K Sell
4,324
-347
-7% -$19.7K ﹤0.01% 2331
2017
Q1
$251K Buy
4,671
+2,658
+132% +$143K ﹤0.01% 2358
2016
Q4
$115K Buy
2,013
+1,155
+135% +$66K ﹤0.01% 2544
2016
Q3
$54K Buy
858
+224
+35% +$14.1K ﹤0.01% 2691
2016
Q2
$36K Buy
634
+553
+683% +$31.4K ﹤0.01% 2674
2016
Q1
$5K Sell
81
-157
-66% -$9.69K ﹤0.01% 3070
2015
Q4
$33K Buy
238
+229
+2,544% +$31.8K ﹤0.01% 2588
2015
Q3
$1K Sell
9
-23
-72% -$2.56K ﹤0.01% 3792
2015
Q2
$5K Buy
+32
New +$5K ﹤0.01% 3628